OCT 24, 2018 10:30 AM PDT

Chemometric Methods for Analysis of 2D 1H-13C Methyl NMR Spectra of Monoclonal Antibodies for Higher Order Structure Characterization

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Research Chemist, Macromolecular Structure and Function Group, National Institute of Standards and Technology (NIST)
    Biography
      Luke W. Arbogast is a Research Chemist in the Biomolecular Measurement Division at the National Institute of Standards and Technology (NIST). His current research focuses on the development and application of state-of-the-art two-dimensional NMR methods to characterize the structure of protein therapeutics. These methods are of particular interest to the biopharmaceutical industry where structural comparability studies are necessary for drug development, drug-quality testing and the benchmarking biosimilars against innovator reference products. In 2016, Luke received the Department of Commerce Silver Award for his work in this area. Prior to his current role at NIST, Luke was a National Research Council Postdoctoral Fellow at the Institute for Bioscience and Biotechnology Research in Rockville, Md. Luke received his B.S. in Chemistry from Virginia Commonwealth University and his Ph.D. in Chemistry from Johns Hopkins University.

    Abstract:

    Two-dimensional (2D) 1H-13C methyl correlated NMR is increasingly being recognized as a powerful tool to characterize the higher order structure (HOS) of monoclonal antibody (mAb) therapeutics. 2D methyl NMR is well suited to the task as spectra can be readily be acquired on intact mAbs at natural isotopic abundance, and even small changes to chemical environment and structure manifest observable changes in the spectra, which can be interpreted at atomic resolution. This makes it possible to apply 2D NMR approaches directly to drug products in order to systematically characterize structural effects. Traditionally, such analysis has involved identifying specific changes to measured resonance peak parameters.  Recently, we have demonstrated a complementary approach using principal component analysis (PCA) to directly analyze the matrix of spectral data, correlating spectra according to similarities and differences in their overall shapes. This approach is particularly well-suited for spectra of mAbs, where many individual peaks may not be well resolved and peak parameters difficult to measure. Here we demonstrate the performance of the PCA method for discriminating structural variation among systematic sets of 2D NMR spectra using the NISTmAb reference material and illustrate how spectral variability identified by PCA may be correlated to structure.

    Learning Objectives: 

    1. 2D 1H-13C Methyl NMR spectra can be readily acquired on monoclonal antibody therapeutics at natural isotopic abundance.
    2. Such spectra are suitable to assess the major conformation(s) of mAb drugs in solution.
    3. Using multivariate statistics, such as principal component analysis mAb spectra can be classified based on minor structural perturbations with low levels of detection.


    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    OCT 01, 2019 8:00 AM PDT
    C.E. CREDITS
    OCT 01, 2019 8:00 AM PDT
    DATE: October 1, 2019TIME: 8:00am PTIn the webinar, Introduction to Characterization of Biomolecules Using Analytical Ultracentrifugation, we discussed the fundamentals of analytical...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources
    Attendees